Back to search

Article

A Bioinformatic Characterisation of the Glyolytic Enzyme ENO1 as a Biomarker of Breast Cancer Progression

2024-01-18

Abstract excerpt

Enolase 1 (ENO1) catalyses glycolysis and is involved in the regulation of multiple signalling pathways. Utilising available online platforms (KM-plotter, ROC-plotter, cBioPortal, G-2-O, MethSurvand, TISIDB), we performed a bioinformatic analysis to establish the prognostic and predictive effects related to ENO1 expression in BC. A network analysis was performed using the Oncomine platform and signalling, epigenet...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5a190136-8cce-566f-a8b6-aec6acbfdd2f
DOI
10.21203/rs.3.rs-3853453/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Bioinformatic Characterisation of the Glyolytic Enzyme ENO1 as a Biomarker of Breast Cancer ProgressionDOI 10.21203/rs.3.rs-3853453/v1
ENO1 as a biomarker of breast cancer progression and metastasis – a bioinformatic approachSemantic proximity
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancersSemantic proximity
Multiomics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacySemantic proximity
The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approachSemantic proximity
Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosisSemantic proximity
The Role of CPT1A as a Biomarker of Breast Cancer Progression – A Bioinformatic AnalysisSemantic proximity
ENO3 promotes colorectal cancer progression by enhancing cell glycolysisSemantic proximity
ALDOC and PGK1 coordinately induce glucose metabolism reprogramming and promote development of colorectal cancerSemantic proximity
Deletion of ENO1 sensitizes pancreatic cancer cells to gemcitabine via MYC/RRM1-mediated glycolysisSemantic proximity
Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites.Semantic proximity
Enolase-1 serves as a biomarker of diagnosis and prognosis in hepatocellular carcinoma patientsSemantic proximity
ERO1α as a potential drug target for breast cancer: a systematic review of current evidenceSemantic proximity
Select a neighboring publication to make it the new centre.